Published in Cancer Weekly, August 23rd, 1999
The controversy raged on in the July 1999 issue of Contemporary OB/GYN ("Should ERT Be Prescribed for Women Who Have Had Breast Cancer'" Contemporary OB/GYN, July 1999;44(7)).
On the "yes" side, William J. Creasman, MD, of the Medical University of South Carolina, asserted that it has been merely the "opinion" of medical providers that ERT is detrimental to patients with a history of breast cancer. The data do not support this opinion, he said. In fact, according to the ACOG Committee Opinion No. 135: "There are no data that indicate an increased risk of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.